Soares do Brito Joaquim, Spranger André, Almeida Paulo, Portela José, Barrientos-Ruiz Irene
Orthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal.
Orthopedics Department, University Hospital of La Paz, Madrid.
EFORT Open Rev. 2021 Aug 10;6(8):641-650. doi: 10.1302/2058-5241.6.200154. eCollection 2021 Aug.
Giant cell tumour of bone (GCT) is a relatively rare, locally aggressive benign neoplasm observed in the long bone epiphyseal-metaphyseal regions of young adults.The optimal treatment strategy for these tumours remains controversial, and a huge amount of contradictory data regarding the functional and oncological outcomes can be found. Therefore, we performed a systematic review intended to investigate the functional and oncological outcomes after surgical treatment of GCTs arising around the knee, namely in the distal femur and proximal tibia.A trend towards better oncological control was found using wide resections, nonetheless, curettage-based techniques achieve a highly acceptable recurrence rate with overall better knee function. A slight advantage favouring proximal tibia GCTs regarding the Musculoskeletal Tumor Society (MSTS) score was also observed.Prospective studies comparing groups of more homogeneous patients, tumours, and treatment options should be developed to obtain more conclusive and definitive results regarding the optimal strategy for treating GCTs. Cite this article: 2021;6:641-650. DOI: 10.1302/2058-5241.6.200154.
骨巨细胞瘤(GCT)是一种相对罕见的、具有局部侵袭性的良性肿瘤,多见于年轻成人长骨的骨骺-干骺端区域。这些肿瘤的最佳治疗策略仍存在争议,并且可以找到大量关于功能和肿瘤学结果的相互矛盾的数据。因此,我们进行了一项系统综述,旨在研究膝关节周围(即股骨远端和胫骨近端)骨巨细胞瘤手术治疗后的功能和肿瘤学结果。采用广泛切除发现有更好的肿瘤学控制趋势,尽管如此,基于刮除术的技术具有高度可接受的复发率,且膝关节整体功能更好。在肌肉骨骼肿瘤学会(MSTS)评分方面,也观察到胫骨近端骨巨细胞瘤有轻微优势。应开展前瞻性研究,比较更同质的患者、肿瘤和治疗方案组,以获得关于骨巨细胞瘤最佳治疗策略更具结论性和确定性的结果。引用本文:2021;6:641 - 650。DOI:10.1302/2058 - 5241.6.200154。